# Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists
> **US Department of Veterans Affairs** · Final rule. · Published 2021-09-20 · Effective 2021-10-20 · 86 FR 52072
## Document
- **Document number:** 2021-20196
- **Category:** va-education
- **Agency:** US Department of Veterans Affairs
- **Federal Register citation:** 86 FR 52072
- **CFR reference:** 38 CFR 17
- **Publication date:** 2021-09-20
- **Effective date:** 2021-10-20
## Abstract

The Department of Veterans Affairs (VA) is amending its medical regulations that govern copayments to conform with recent statutory requirements. VA is eliminating the copayment requirement for opioid antagonists furnished to veterans who are at high risk of overdose of a specific medication or substance in order to reverse the effect of such an overdose. VA is also clarifying that no copayment is required for the provision of education on the use of opioid antagonists. This final rule is an essential part of VA's attempts to help veterans at high risk of overdose.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2021/09/20/2021-20196/elimination-of-copayment-for-opioid-antagonists-and-education-on-use-of-opioid-antagonists)
---
*MORVS · CC0 1.0*